4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-106752
Interim CEO & General Counsel gave up 6,638 shares (to pay taxes)
- Interim CEO & General Counsel acquired 15,626 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2026-09-08 | Option exercise | +15,626 | 602,085 | D: show line 1 in the form | ||
| Vogt Frederick G Interim CEO & General Counsel | 2026-09-08 | Shares withheld for taxes | −6,638 | $8.70 | $57,751 | 595,447 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2026-09-08 | Option exercise · Restricted Stock Units | −15,626 | 93,756 | D: show line 3 in the form |
Loading xslF345X06/tm2625111-3_4seq1.xml…